Scribe Therapeutics Inc. SCTX
17.36 USD +0.68 (+4.08%)
At closeNov 10, 2026, 4:00 PM EST
17.36 0.00 0.00%
After hours · Nov 10, 4:00 PM ET
16.01 Day range 18.30
13.50 52-week range 39.60
- YTD
- -8.49%
- 1 year
- -8.49%
News
globenewswire.com Scribe Therapeutics to Participate in Upcoming Healthcare Investor Conferences ALAMEDA, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Scribe Therapeutics Inc. (“Scribe Therapeutics” or “the Company”) (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built…
benzinga.com Scribe Therapeutics To Present Data In American Heart Association’s Scientific Sessions On Its Three Clinical Programs Scribe Therapeutics Inc. ("Scribe Therapeutics" or "the Company") (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend…
globenewswire.com Scribe Therapeutics to Present Updated Data on PCSK9-Targeting Epigenetic Silencing and LPA-Targeting Gene Editing Programs at American Heart Association (AHA) Scientific Sessions 2026 Late-breaking presentation will report long-term durability preclinical data for STX-1150, Scribe's lead epigenetic silencing therapy for LDL cholesterol reduction now in clinical trials A second…
benzinga.com Bending Spoons, Liquidia, Verastem And Other Big Stocks Moving Higher On Wednesday U.S. stocks mostly fell, but Bending Spoons surged 40% after Berkshire’s $330M investment. Liquidia and Verastem also posted strong gains.